Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

Bibliographic Details
Main Author: Jaggar, Sarah F.
Corporate Authors: United States. General Accounting Office, United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations
Format: Government Document Book
Language:English
Published: Washington, D.C. : The Office ; [1996]
Series:Testimony ; GAO/T-HEHS-96-216.
Subjects:
Online Access:Adobe Acrobat Reader required

MARC

LEADER 00000cam a2200000 a 4500
001 in00001626667
005 20211202193544.0
008 961022s1996 dcu b f000 0 eng c
035 |a (OCoLC)ocm35774983 
037 |a 157507  |b GAO (202) 512-6000 (Voice); (202) 512-6061 (Fax)  |f paper copy 
040 |a GAO  |c GAO  |d GPO  |d DLC  |d MvI  |d UtOrBLW 
042 |a pcc 
043 |a n-us--- 
049 |a WWW 
074 |a 0546-D-01 (online) 
086 0 |a GA 1.5/2:T-HEHS-96-216 
090 |a HD9666.4  |b .J3317 
100 1 |a Jaggar, Sarah F. 
245 1 0 |a Prescription drug pricing :  |b implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /  |c United States General Accounting Office. 
246 3 0 |a Implications for retail pharmacies 
264 1 |a Washington, D.C. :  |b The Office ;  |c [1996] 
264 2 |a Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) :  |b The Office [distributor], 
300 |a 8 pages ;  |c 28 cm. 
336 |a text  |b txt  |2 rdacontent 
337 |a unmediated  |b n  |2 rdamedia 
338 |a volume  |b nc  |2 rdacarrier 
490 1 |a Testimony ;  |v GAO/T-HEHS-96-216 
500 |a Not distributed to depository libraries in a physical form. 
500 |a "September 19, 1996." 
504 |a Includes bibliographical references. 
530 |a Available via Internet from the GPO Access web site. Address as of 5/21/2001: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:he96216t.pdf; current access is available via PURL. 
650 0 |a Prescription pricing  |z United States. 
650 0 |a Drugs  |x Prices  |z United States. 
650 0 |a Drugstores  |z United States. 
710 1 |a United States.  |b General Accounting Office. 
710 1 |a United States.  |b Congress.  |b House.  |b Committee on Commerce.  |b Subcommittee on Oversight and Investigations. 
830 0 |a Testimony ;  |v GAO/T-HEHS-96-216. 
856 4 1 |u https://purl.fdlp.gov/GPO/LPS12202  |z Adobe Acrobat Reader required  |t 0 
999 |a MARS 
999 f f |s 21d6c96f-7155-3801-ac96-e70d1c84638e  |i b3674a98-e0f6-3b8c-86bc-d05b8a49e934  |t 0 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |d Available Online  |t 0  |e GA 1.5/2:T-HEHS-96-216  |h Superintendent of Documents classification 
998 f f |a GA 1.5/2:T-HEHS-96-216  |t 0  |l Available Online